TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD

Tianjin Chase Sun Pharmaceutical Co.,Ltd

300026

CNE100000GF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 04/06/2024 am IST			5-day change	1st Jan Change
3.56 ^CNY	-0.84%		-1.66%	-16.04%

29/03	Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023	CI
01/03	Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	MT

Tianjin Chase Sun Pharmaceutical Co., Ltd. Elects Wang Shengtian as an Independent Director

December 29, 2017 at 08:02 pm IST

Tianjin Chase Sun Pharmaceutical Co., Ltd. at its extraordinary general meeting held on December 28, 2017, elected Wang Shengtian as an independent director.

Latest news about Tianjin Chase Sun Pharmaceutical Co.,Ltd

Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023	29/03	CI
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	01/03	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Tianjin Chase Sun Pharma’s Muscle Relaxant Passes Drug Consistency Test	22/23/22	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for A Shares for the Year 2022, Payable on 12 May 2023	09/23/09	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2022	26/23/26	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2022	01/23/01	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 19, 2022	13/22/13	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021	23/22/23	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021	01/22/01	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Dividend on A Shares for the Year 2020, Payable on June 10, 2021	05/21/05	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Cash Dividend for 2020	20/21/20	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	27/21/27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2020	01/21/01	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

Duration

Period

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

More charts

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Chase Sun Pharmaceutical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.56 CNY

Average target price

4 CNY

Spread / Average Target

+12.36%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-16.04%	148.92Cr
DONG-E-E-JIAO CO.,LTD.	+39.90%	601.38Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.06%	410.87Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.94%	328.13Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.63%	282.82Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.17%	230.69Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.13%	190.16Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-5.16%	154.98Cr
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+52.16%	150.5Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-16.78%	148.63Cr

Alternative Medicine